Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼

Sunday, November 14, 2010

[18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy.

Abstract

AIM: The most accepted standard duration of neoadjuvant chemotherapy (na-CHT) before debulking surgery for advanced ovarian cancer (AOC) is 3 courses. However a percentage of patients could benefit from additional courses......

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.